Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Core Insights - Sight Sciences, Inc. reported a quarterly loss of $0.16 per share, better than the Zacks Consensus Estimate of a loss of $0.26, representing an earnings surprise of +38.46% [1] - The company posted revenues of $19.91 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 15.98% [2] - Sight Sciences shares have increased approximately 38.2% year-to-date, outperforming the S&P 500's gain of 15.6% [3] Financial Performance - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is -$0.24 on revenues of $19.75 million, and for the current fiscal year, it is -$1.02 on revenues of $73.99 million [7] Industry Outlook - The Medical - Instruments industry, to which Sight Sciences belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]